• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. MCRYL UD 18IN 3-0 S/A PS-2 PRM MP; SUTURE, ABSORBABLE, SYNTHETIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. MCRYL UD 18IN 3-0 S/A PS-2 PRM MP; SUTURE, ABSORBABLE, SYNTHETIC Back to Search Results
Model Number Y497G
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Necrosis (1971); Not Applicable (3189)
Date of Event 01/01/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).A manufacturing record evaluation was performed for the finished device qbmhsz batch number, and no non-conformances were identified.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.The patient demographic info: age, gender, weight, bmi at the time of index procedure.Date of the index surgical procedure? the diagnosis and indication for the index surgical procedure? what was the onset date of necrosis following the index surgery? did the patient experience an infection? if yes, were cultures performed? results? date the debridement and reapproximation were performed? what was the appearance of the monocryl suture during the second procedure? where and how was the dermabond device used (what layer of tissue and how many layers applied)? was a dressing applied over the dermabond? if yes, please describe, including brand name.How many days post-op was the dressing in place? what was the frequency of dressing changes? has the patient had prior exposure to dermabond, prineo or skin adhesives? lot number of dermabond used.Other relevant patient history / concomitant medications? if applicable, will product be returned? what is the patient¿s current status? note: event related to topical skin adhesive reported via mw# 2210968-2020-07103.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event or Problem Description
It was reported that the patient underwent a hip procedure on an unknown date and suture was used.It was reported that suture was used on cuticular layer and topical skin adhesive was used with aquacell dressing.Six weeks post-op, the patient had necrotic tissue along the suture line.The patient underwent debridement and re-approximation with nylon suture.There was no report of infection.Additional information has been requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MCRYL UD 18IN 3-0 S/A PS-2 PRM MP
Common Device Name
SUTURE, ABSORBABLE, SYNTHETIC
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876
MDR Report Key10556642
Report Number2210968-2020-07102
Device Sequence Number3749754
Product Code GAN
UDI-Device Identifier10705031059399
UDI-Public10705031059399
Combination Product (Y/N)N
Initial Reporter StateCO
Initial Reporter CountryUS
PMA/510(K) Number
K964072
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 08/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/31/2025
Device Model NumberY497G
Device Catalogue NumberY497G
Device Lot NumberQBMHSZ
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/27/2020
Initial Report FDA Received Date09/18/2020
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-